These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12680624)

  • 41. Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes.
    Asmar M; Højberg PV; Deacon CF; Hare K; Holst JJ; Madsbad S
    Regul Pept; 2010 Feb; 160(1-3):175-80. PubMed ID: 20005261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus.
    Deacon CF; Schleser-Mohr S; Ballmann M; Willms B; Conlon JM; Creutzfeldt W
    Acta Endocrinol (Copenh); 1988 Dec; 119(4):549-54. PubMed ID: 3059740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus.
    Festa A; Shnawa N; Schernthaner G; Haffner SM
    Exp Clin Endocrinol Diabetes; 1999; 107(7):447-52. PubMed ID: 10595596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J; Mehta R; Donnelly R; Idris I
    Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance.
    Shimizu M; Kawazu S; Tomono S; Ohno T; Utsugi T; Kato N; Ishi C; Ito Y; Murata K
    Diabetes Care; 1996 Jan; 19(1):8-11. PubMed ID: 8720525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study.
    Mykkänen L; Zaccaro DJ; Hales CN; Festa A; Haffner SM
    Diabetologia; 1999 Sep; 42(9):1060-6. PubMed ID: 10447516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
    Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
    J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.
    Nagi DK; Ali VM; Yudkin JS
    Diabet Med; 1996 Aug; 13(8):753-7. PubMed ID: 8862952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum Vitamin D and Its Upregulated Protein, Thioredoxin Interacting Protein, Are Associated With Beta-Cell Dysfunction in Adult Patients With Type 1 and Type 2 Diabetes.
    Omar DF; Kamal MM; El-Hefnawy MH; El-Mesallamy HO
    Can J Diabetes; 2018 Dec; 42(6):588-594. PubMed ID: 29980378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are specific serum insulin levels low in impaired glucose tolerance and type II diabetes?: measurement with a radioimmunoassay blind to proinsulin, in the population of Wadena, Minnesota.
    Goetz FC; French LR; Thomas W; Gingerich RL; Clements JP
    Metabolism; 1995 Oct; 44(10):1371-6. PubMed ID: 7476300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
    Pfützner A; Kunt T; Hohberg C; Mondok A; Pahler S; Konrad T; Lübben G; Forst T
    Diabetes Care; 2004 Mar; 27(3):682-7. PubMed ID: 14988285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes.
    Dornhorst A; Davies M; Anyaoku V; Hampton SM; Elkeles RS; Beard RW; Johnston DG
    Clin Endocrinol (Oxf); 1991 Mar; 34(3):211-3. PubMed ID: 2036730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
    Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
    Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG; Owusu SK; Schuster DP; Osei K
    S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD; Balfour JA
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus. Effect of sulfonylurea therapy.
    Fukase N; Manaka H; Sugiyama K; Takahashi H; Igarashi M; Daimon M; Yamatani K; Tominaga M; Sasaki H
    Acta Diabetol; 1995 Oct; 32(3):165-9. PubMed ID: 8590785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.
    Forst T; Falk A; Andersen G; Fischer A; Weber MM; Voswinkel S; Heise T; Kapitza C; Plum-Mörschel L
    Diabetes Obes Metab; 2017 Apr; 19(4):489-495. PubMed ID: 28009472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitus.
    Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
    Diabet Med; 1994; 11(1):71-8. PubMed ID: 8181257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.